Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

Modified-Release Drug Delivery Systems: Stimuli-Activated

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Polymer Capsules with Volatile Organic Compounds as Reference Materials for Controlled Emission.

ACS applied materials & interfaces·2024

Same author

Single-Atom Catalysts through Pressure-Controlled Metal Diffusion.

Journal of the American Chemical Society·2024

Same author

Interfacial Denaturation at the Droplet Simplifies the Formation of Drug-Loaded Protein Nanocapsules to Enhance Immune Response of Cells.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2024

Same author

Size-Dependent Photocatalytic Reactivity of Conjugated Microporous Polymer Nanoparticles.

Advanced materials (Deerfield Beach, Fla.)·2024

Same author

Ion and Molecular Sieving With Ultrathin Polydopamine Nanomembranes.

Advanced materials (Deerfield Beach, Fla.)·2024

Same author

Supramolecular Assembly in Live Cells Mapped by Real-Time Phasor-Fluorescence Lifetime Imaging.

Journal of the American Chemical Society·2024

Search research articles

Related Experiment Video

Updated: May 20, 2026

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Suppressing unspecific cell uptake for targeted delivery using hydroxyethyl starch nanocapsules.

Grit Baier¹, Daniela Baumann, Jörg Max Siebert

¹Max Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany.

Biomacromolecules

|August 1, 2012

Summary

Researchers developed novel hydroxyethyl starch (HES) nanocapsules as a non-toxic alternative to PEG for targeted drug delivery. These HES nanocarriers demonstrate specific uptake in cancer cells via folic acid targeting.

More Related Videos

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Related Experiment Videos

Last Updated: May 20, 2026

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Area of Science:

Biomaterials Science
Nanotechnology
Drug Delivery Systems

Background:

Developing nanocarriers with stealth properties for targeted in vivo delivery is crucial but challenging.
Poly(ethylene glycol) (PEG) is commonly used for stealth properties but can have toxicity concerns.
A non-toxic alternative is needed for effective nanocarrier-based therapies.

Purpose of the Study:

To synthesize and characterize cross-linked hydroxyethyl starch (HES) nanocapsules as a non-toxic alternative to PEG.
To functionalize HES nanocapsules with folic acid for targeted delivery to folate receptor-overexpressing cancer cells.
To evaluate the specific cellular uptake of functionalized HES nanocapsules.

Main Methods:

Synthesis of cross-linked HES nanocapsules (170-300 nm) with a molecular weight of 200,000 g/mol.
Covalent coupling of a folic acid conjugate to HES nanocapsules, confirmed by FTIR and NMR spectroscopy.
Assessment of coupling efficiency using fluorescence spectroscopy and cellular uptake studies via confocal laser scanning microscopy (CLSM) and flow cytometry.

Main Results:

HES nanocapsules exhibited no nonspecific cellular uptake.
Folic acid conjugation enabled specific targeting and uptake into folate receptor-positive cells.
FTIR, NMR, and fluorescence spectroscopy confirmed successful folic acid coupling.

Conclusions:

Cross-linked HES nanocapsules are a promising non-toxic alternative to PEG for nanocarrier development.
Folic acid functionalization effectively targets cancer cells overexpressing folate receptors.
These HES nanocapsules show potential for targeted in vivo drug delivery applications.